APArmalya Pritazahra

Armalya Pritazahra

*This is an algorithmically generated author record based on publicly available information.

Armalya Pritazahra has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Benign Origins to Final Moments: Right Ventricular Outflow Tract Premature Ventricular Complexes Culminating in Asystole on Holter Monitoring

    by Sunu Budhi Raharjo, Sai Vhimal Raj, Armalya Pritazahra, Dicky Armein Hanafy, Dony Yugo Hermanto, Yoga Yuniadi

    Background: Premature Ventricular Complexes (PVCs) are a common cardiac arrhythmia typically of benign nature. Their origin, the right ventricular outflow tract (RVOT), is often a point of interest due to its implications in treatment strategies. While the vast majority of PVC RVOT cases remain uneventful, there are isolated incidents that challenge this common perception. Continuous monitoring methods, such as the Holter monitor, have provided invaluable insights into the real-world dynamics of arrhythmias, capturing rare events that can be of paramount clinical significance. Case Illustration: A 60-year-old female, presented to Harapan Kita Hospital Jakarta in May with palpitations. Over several visits, physical examinations consistently indicated a heart within normal parameters, absent of murmurs or gallop. Successive ECGs revealed persistent PVCs of RVOT origin. Despite medical intervention, her arrhythmic pattern persisted. By September, her symptoms had diversified, including occasional chest pain, nausea, and dyspnea. An ECG, yet again, confirmed PVCs with RVOT origin. During a Holter monitoring session on September, a distressing sequence of events was captured. The monitor initially registered a non-sustained Ventricular Tachycardia (VT). which escalated to sustained VT, ventricular fibrillation, and culminating in asystole, marking the patient's final moments. Conclusions: The pathophysiological journey from benign PVCs of RVOT origin to a fatal arrhythmic event underscores the unpredictability and inherent dangers of cardiac arrhythmias. This case is a reminder of the critical importance of persistent monitoring, timely interventions, and the nuanced understanding of conditions conventionally deemed 'benign'.

  • Open Access

    MicroRNA regulation of PPARG Signalling: Therapeutic implications for pulmonary hypertension

    by Renzhi Su, Armalya Pritazahra, ShirinC.C. Saverimuttu, RuthC. Lovering, LucieH. Clapp, JigishaA. Patel


  • Open Access

    Functional Genomics Validation of PPAR gamma Signalling in PASMCs: Therapeutic Implications for Pulmonary Arterial Hypertension

    by Renzhi Su, Armalya Pritazahra, Shirin C.C. Saverimuttu, Lucie H Clapp, Ruth C Lovering, Jigisha A Patel

    Gene Ontology (GO) is a tool which provides gene functional annotations, an essential resource for knowledge discovery and the analysis of biological datasets. Although considerable research has quantified the functional similarity between gene products and physiological processes, there is a need to identify which of these may contribute to pathophysiological states in humans. Previous studies have identified the role of PPARG in multiple signalling pathways, particularly those of TGFB1 and BMP2, in pulmonary artery smooth muscle cells and their relation to pulmonary arterial hypertension (PAH). To enhance the description of PPARG in the GO resource we systematically curated the proteins it interacts with and its physiological role in PASMCs. In addition, we curated the microRNAs that play a role in PAH through their regulation of PPARG expression and their downstream impact on cellular processes. This project curated experimental evidence describing 101 human miRNAs that regulate the expression of 17 PPARG signalling pathway-relevant proteins. Of these, 91 of our curated miRNAs were previously unannotated in terms of directly regulating the expression of these priority proteins. By submitting these annotations to the GO Consortium database, we have significantly expanded the breadth and depth of the GO description of PPARG-associated signalling pathways.

  • Open Access

    Hypertension and Abnormal Renal Function and the Risk of Ischaemic Stroke in Anticoagulated Type 1 Evaluated Heart Valves, Rheumatic or Artificial Valvular AF

    by Rena Winanti, Sunu Budhi Raharjo, Rina Ariani, Dicky Armein Hanafy, Celly Anantaria Atmadikoesoemah, Prima Almazini, Armalya Pritazahra, Yoga Yuniadi

    Background: AF substantially increases the risk of stroke. The most widely used risk prediction score for AF is CHA2DS2-VASC. Previous studies have mainly focused on its efficacy among patients with non-valvular AF. The few studies that have considered patients with valvular AF highlight the tool’s poor scoring accuracy. Objective: This study was conducted to evaluate the clinical factors and echocardiographic parameters related to the incidence of ischaemic stroke in anticoagulated evaluated heart valves, rheumatic or artificial (EHRA) type 1 valvular AF patients. Methods: We conducted a retrospective cohort study using data from the Indonesian Registry on Atrial Fibrillation (OneAF). Patients with EHRA type 1 valvular AF recorded in the registry from January 2015 to December 2019 were included in the study. Results: The incidence of ischaemic stroke was 17 (5.2%) out of 329 AF patients with mitral stenosis or mechanical prosthetic valves. A multivariate analysis showed that two clinical factors: hypertension (OR 5.59; 95% CI [1.93–16.15]; p=0.001) and estimated glomerular filtration rate (eGFR) ≤59 ml/min/m2 (OR 3.62; 95% CI [1.30–10.02]; p=0.013), were independently associated with the incidence of ischaemic stroke. No echocardiographic parameters were associated with the incidence of ischaemic stroke in this population. Conclusion: Hypertension and impaired renal function elevated the risk of ischaemic stroke in the patient population. Further research is necessary to determine the proper scoring system for predicting ischaemic stroke in this subgroup.